SPAGO.ST

Spago Nanomedical AB (publ) [SPAGO.ST] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SPAGO.ST Stock Summary

Top 10 Correlated Stocks

SPAGO.ST


In the News

SPAGO.ST Financial details

Company Rating
Neutral
Market Cap
65.17M
Income
-38.53M
Revenue
1.2M
Book val./share
0.35
Cash/share
0.38
Dividend
-
Dividend %
-
Employees
13
Optionable
No
Shortable
Yes
Earnings
07 Feb 2024
P/E
-0.77
Forward P/E
-
PEG
0.22
P/S
116.76
P/B
0.19
P/C
0.88
P/FCF
-1.8
Quick Ratio
4.68
Current Ratio
5.25
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.39
EPS next Y
-
EPS next Q
-
EPS this Y
-27.12%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.73%
Revenue last 5Y
109.23%
Revenue Q/Q
169.74%
EPS Q/Q
6.02%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-23%
ROE
-22%
ROC
-0.25%
Gross Margin
-3218%
Oper. Margin
-6726%
Profit Margin
-6582%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.195801-0.859615
52W High
-
52W Low
-
RSI
58
Rel Volume
0.87
Avg Volume
128.55K
Volume
111.78K
Perf Week
25%
Perf Month
8.41%
Perf Quarter
32.94%
Perf Half Y
21.38%
-
-
-
-
Beta
2.098
-
-
Volatility
0.02%, 0.01%
Prev Close
10.93%
Price
0.335
Change
18.37%

SPAGO.ST Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00.010.020.020.01
Net income per share
-0.9-0.65-0.93-0.59-0.43
Operating cash flow per share
-0.95-0.65-0.85-0.57-0.46
Free cash flow per share
-1.75-0.87-0.96-0.63-0.46
Cash per share
0.540.981.250.930.46
Book value per share
6.115.514.422.950.42
Tangible book value per share
0.510.961.160.860.42
Share holders equity per share
6.115.514.422.950.42
Interest debt per share
00000
Market cap
337.68M246.92M200.78M42.09M32.04M
Enterprise value
325.54M218.47M148.32M-20.01M-13.18M
P/E ratio
-16.65-13.06-5.14-1.07-0.76
Price to sales ratio
11.26K721.98304.2139.9326.63
POCF ratio
-15.86-13.16-5.64-1.1-0.71
PFCF ratio
-8.55-9.82-5-1-0.71
P/B Ratio
2.451.551.090.210.78
PTB ratio
2.451.551.090.210.78
EV to sales
10.85K638.8224.73-18.99-10.95
Enterprise value over EBITDA
-16.45-11.75-3.830.520.28
EV to operating cash flow
-15.29-11.64-4.170.520.29
EV to free cash flow
-8.24-8.69-3.690.480.29
Earnings yield
-0.06-0.08-0.19-0.93-1.32
Free cash flow yield
-0.12-0.1-0.2-1-1.41
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
0.611.531.361.60.96
Current ratio
4.679.487.987.424.52
Interest coverage
000147.260
Income quality
1.050.990.910.971.07
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
208.0715.2411.437.660
Research and developement to revenue
79.639.7628.516.2220.35
Intangibles to total assets
0.90.810.710.680
Capex to operating cash flow
0.860.340.130.10
Capex to revenue
-607.13-18.67-7.01-3.630
Capex to depreciation
-51.02-17.64-12.31-10.760
Stock based compensation to revenue
00000
Graham number
11.138.999.646.252.02
ROIC
-0.15-0.12-0.21-0.2-1.14
Return on tangible assets
-1.41-0.61-0.7-0.59-0.8
Graham Net
0.430.911.130.810.35
Working capital
10.67M26.69M47.58M56.45M40.43M
Tangible asset value
11.5M27.77M48.65M57.3M41.51M
Net current asset value
10.67M26.69M47.58M56.45M40.43M
Invested capital
00000
Average receivables
713.5K1.41M1.66M2.53M1.76M
Average payables
1.34M726K2.39M4.29M5.56M
Average inventory
-713.5K-713.5K1-1.55M-1.55M
Days sales outstanding
17.36K1.48K1.07K1.09K112.26
Days payables outstanding
-73.06446.3880.8103.5397.4
Days of inventory on hand
198.5700-67.770
Receivables turnover
0.020.250.340.343.25
Payables turnover
-50.824.523.533.75
Inventory turnover
1.84758K17.44M-5.3923.95M
ROE
-0.15-0.12-0.21-0.2-1.02
Capex per share
-0.81-0.22-0.11-0.060

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000.01
Net income per share
-0.12-0.15-0.08-0.07-0.08
Operating cash flow per share
-0.08-0.17-0.13-0.05-0.11
Free cash flow per share
-0.12-0.17-0.13-0.05-0.11
Cash per share
0.650.470.330.270.38
Book value per share
2.071.921.841.760.35
Tangible book value per share
0.60.440.340.260.35
Share holders equity per share
2.071.921.841.760.35
Interest debt per share
00000
Market cap
59.99M77.13M61.51M32.28M38.86M
Enterprise value
-2.11M32.02M30.12M6.3M-6.35M
P/E ratio
-1.32-1.36-1.95-1.13-1.03
Price to sales ratio
422.44876.42539.56119.1153.17
POCF ratio
-7.97-4.88-5.11-7.08-3.07
PFCF ratio
-5.35-4.88-5.11-7.08-3.07
P/B Ratio
0.30.420.350.190.94
PTB ratio
0.30.420.350.190.94
EV to sales
-14.89363.85264.1923.26-8.69
Enterprise value over EBITDA
0.19-2.2-3.75-0.870.57
EV to operating cash flow
0.28-2.03-2.5-1.380.5
EV to free cash flow
0.19-2.03-2.5-1.380.5
Earnings yield
-0.19-0.18-0.13-0.22-0.24
Free cash flow yield
-0.19-0.2-0.2-0.14-0.33
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
5.723.13.913.594.05
Current ratio
7.426.618.915.254.52
Interest coverage
67.0258.75000
Income quality
0.661.121.50.631.35
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
021.5000
Research and developement to revenue
39.55109.325.169.478.52
Intangibles to total assets
0.680.740.80.830
Capex to operating cash flow
0.490000
Capex to revenue
-26.020000
Capex to depreciation
-45.060000
Stock based compensation to revenue
00000
Graham number
2.362.531.851.720.79
ROIC
-0.06-0.08-0.05-0.04-0.27
Return on tangible assets
-0.17-0.29-0.22-0.24-0.18
Graham Net
0.570.410.290.210.29
Working capital
56.45M40.97M31.53M23.61M40.43M
Tangible asset value
57.3M41.76M32.35M24.33M41.51M
Net current asset value
56.45M40.97M31.53M23.49M40.43M
Invested capital
00000
Average receivables
1.57M1.62M47K0185K
Average payables
2.98M4.61M2.77M1.93M4.61M
Average inventory
-1.55M-389K1.16M00.5
Days sales outstanding
1.99K96.140045.55
Days payables outstanding
76.4342.3733.27101.98100.24
Days of inventory on hand
-50.0321.8000
Receivables turnover
0.050.94001.98
Payables turnover
1.182.122.70.880.9
Inventory turnover
-1.84.13005.74M
ROE
-0.06-0.08-0.04-0.04-0.23
Capex per share
-0.040000

SPAGO.ST Frequently Asked Questions

What is Spago Nanomedical AB (publ) stock symbol ?

Spago Nanomedical AB (publ) is a SE stock and trading under the symbol SPAGO.ST

What is Spago Nanomedical AB (publ) stock quote today ?

Spago Nanomedical AB (publ) stock price is $0.335 today.

Is Spago Nanomedical AB (publ) stock public?

Yes, Spago Nanomedical AB (publ) is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap